ODDB.org: Open Drug Database

Almirall AG - Ilumetri 200 mg/2 ml, Injektionslösung

Swissmedic Registration	66784	Sequence	02
Product name	Ilumetri 200 mg/2 ml	Description	Injektionslösung
ATC-Classification	L04AC17	ATC-Description	Tildrakizumab
Introduction of Sequence	24.08.2023

Composition

tildrakizumabum 200 mg, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, saccharum, aqua ad iniectabile q.s. ad solutionem pro 2 ml.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Tildrakizumabum	200mg / 2ml

BAG: Active Agent	Dose
Tildrakizumabum	200 mg

Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 80
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003		2962.66	3238.50	B	SL	No

2025	©ywesee GmbH